Healthy donors needed to supply immune cells for future drug research

NCT ID NCT07663565

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study collects peripheral blood mononuclear cells (immune cells) from 200 healthy volunteers aged 18 to 40 using a process called apheresis. The cells will be used in the lab to study how they grow and function, helping researchers develop new drugs. No treatment or medication is given to participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help scientists develop new drugs or cell therapies by providing a source of immune cells for lab testing.

What could go wrong

This is an early-stage collection study, not a treatment trial. It does not test any drug or therapy on participants, so there is no direct health benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PBMCS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Anhui Medical University

    RECRUITING

    Hefei, Anhui, 230001, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Bengbu Medical University

    SUSPENDED

    Bengbu, Anhui, 233000, China